Barton P. Bandy is President and CEO of ReShape Lifesciences Inc.. Currently has a direct ownership of 773,098 shares of RSLS, which is worth approximately $4.45 Million. The most recent transaction as insider was on Aug 05, 2022, when has been sold 11,674 shares (Common Stock, $0.001 par value per share) at a price of $0.47 per share, resulting in proceeds of $5,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 773K
0% 3M change
0% 12M change
Total Value Held $4.45 Million

Barton P. Bandy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2022
SELL
Open market or private sale
$5,487 $0.47 p/Share
11,674 Reduced 1.49%
773,098 Common Stock, $0.001 p...
Jul 01 2022
SELL
Open market or private sale
$6,293 $0.55 p/Share
11,442 Reduced 1.44%
784,772 Common Stock, $0.001 p...
Jun 01 2022
SELL
Open market or private sale
$10,857 $0.96 p/Share
11,309 Reduced 1.4%
796,214 Common Stock, $0.001 p...
May 05 2022
SELL
Open market or private sale
$8,791 $0.77 p/Share
11,417 Reduced 1.39%
807,523 Common Stock, $0.001 p...
Apr 01 2022
SELL
Open market or private sale
$12,501 $1.13 p/Share
11,063 Reduced 1.33%
818,940 Common Stock, $0.001 p...
Feb 28 2022
SELL
Open market or private sale
$6,930 $1.06 p/Share
6,538 Reduced 0.78%
830,003 Common Stock, $0.001 p...
Jan 31 2022
SELL
Open market or private sale
$10,155 $1.22 p/Share
8,324 Reduced 0.99%
836,541 Common Stock, $0.001 p...
Jan 04 2022
SELL
Open market or private sale
$12,798 $1.79 p/Share
7,150 Reduced 0.84%
844,865 Common Stock, $0.001 p...
Dec 02 2021
SELL
Open market or private sale
$24,571 $1.83 p/Share
13,427 Reduced 1.55%
852,015 Common Stock, $0.001 p...
Nov 02 2021
SELL
Open market or private sale
$36,328 $2.69 p/Share
13,505 Reduced 1.54%
865,442 Common Stock, $0.001 p...
Oct 01 2021
SELL
Open market or private sale
$34,805 $2.77 p/Share
12,565 Reduced 1.41%
878,947 Common Stock, $0.001 p...
Sep 10 2021
SELL
Open market or private sale
$851,088 $2.89 p/Share
294,494 Reduced 24.83%
891,512 Common Stock, $0.001 p...
Jul 22 2021
BUY
Grant, award, or other acquisition
-
1,186,006 Added 50.0%
1,186,006 Common Stock, $0.001 p...
BPB

Barton P. Bandy

President and CEO
San Clemente, CA

Track Institutional and Insider Activities on RSLS

Follow ReShape Lifesciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSLS shares.

Notify only if

Insider Trading

Get notified when an Re Shape Lifesciences Inc. insider buys or sells RSLS shares.

Notify only if

News

Receive news related to ReShape Lifesciences Inc.

Track Activities on RSLS